Podcast Summary: "The Healing Power of Mushrooms: Mental Health & Microdosing with Alli Schaper"

Kreatures Of Habit Podcast with Michael Chernow
Release Date: January 21, 2026
Guest: Alli Schaper (Entrepreneur, Functional & Psychedelic Mushroom Advocate, SuperMush Founder)

Episode Overview

This episode delves into the world of mushrooms—exploring their ancient history, evolving role in mental health, and personal healing stories. Host Michael Chernow and guest Alli Schaper candidly discuss microdosing, sobriety, grief, addiction, and the difference between functional and psychedelic mushrooms. They unpack scientific research, share personal and family experiences, and discuss the future of mushroom accessibility and legalization. The episode is equal parts educational, vulnerable, and inspiring for anyone curious about plant medicine, mental health, or self-exploration.

Key Themes and Discussion Points

1. Ancient Origins, Sacred Use & Scientific Evolution

• Mushrooms (both functional and psychedelic) have a long history in human civilization—as food, medicine, and spiritual tools.
  • Alli: "You can literally look back and 5,000 years ago find a caveman that was fossilized. Otzi the Caveman ... had mushrooms fossilized with him." (19:30)
• Terence McKenna’s theory: Psychedelic consumption may have influenced brain development in early humans.
• Modern science is confirming therapeutic effects: New neural pathways, neuroplasticity, trauma processing, and more.

2. Personal and Family Healing with Mushrooms

• Alli shares how introducing functional and later psychedelic mushrooms to her parents changed their approach to health and grief.
  • After her father’s death, their prior experience with psychedelics helped them process grief intentionally, rather than relying on traditional pharmaceuticals that can blunt emotions.
  • Alli: “My mom is the biggest advocate for these as therapies. She uses them intentionally, occasionally, and it’s helped her process grief in a way that’s very deep, very intense, but really healthy.” (07:46)

3. Sobriety, Addiction, and the Complexity of Plant Medicine

• Michael expresses hesitancy to try psychedelics because of his recovery journey—but is drawn to the research and healing potential.
  • Concern about whether intentional plant medicine use would jeopardize his sobriety or identity as a sober person.
  • Michael: “In recovery, we are taught that any mood or mind-altering substance is going to take you off this path. However, SSRIs and other mental health medicine are considered okay.” (28:01)
  • Alli highlights studies showing that microdosing psilocybin can reduce addictive behaviors, promote health motivation, and is nonaddictive.
• Nuance in the difference between pharmaceuticals (SSRIs, Adderall) and psilocybin’s mechanisms and risk profiles explained.
  • Alli: “Psilocybin is non-addictive...most commonly, you’ll see two weeks on, one week off, four to five days per week. You don’t develop dependency.” (24:12; 26:38)

4. Functional Mushrooms vs. Psychedelic Mushrooms

• Functional Mushrooms (lion’s mane, cordyceps, turkey tail): Legal, non-psychoactive, used for cognitive health, immune support, and systemic balance.
  • Used in supplements, coffee, snacks and backed by traditional Chinese medicine and recent science.
  • Alli’s company, SuperMush, is designed to make these accessible and appealing.
  • Alli: “If you look at what lion’s mane does to your brain, it’s incredible...it’s one of the only things that can help slow neurodegeneration with age.” (12:10; 62:06)
• Psychedelic Mushrooms (psilocybin): Hallucinogenic, currently illegal in most regions, but legal therapeutic use rising. Used for mental health breakthroughs, neuroplasticity, and, in some studies, as an alternative for depression, anxiety, trauma, and addiction.

5. Microdosing Explained

• Subperceptual doses—no hallucinogenic effect, but subtle improvements in mood, creativity, focus, and well-being.
  • Alli: “Microdosing increased convergent and divergent thinking. 39% of people microdosing psilocybin were also taking lion’s mane – they work synergistically.” (26:36)
• Protocols vary (two days on/one day off, five days on/two days off); break periods to avoid tolerance.
• Supported by science: Large studies show microdosing increases health-motivated behaviors and can support addiction recovery.

6. The Role of Intention, Set, and Setting

• Both Michael and Alli stress the need for intention and proper guidance—especially for those in recovery or processing emotional trauma.
  • Set (mindset) and setting (environment) are crucial for a positive, transformational psychedelic experience.
• Stigma persists, especially in sober communities, but societal and legal attitudes are shifting rapidly.

7. Legalization, Policy, and Advocacy

• SuperMush is focused on the legal, functional mushroom space, but Alli is also deeply involved in nonprofit advocacy for safe, legal access to psychedelics (The Microdosing Collective).
• Legal landscape: Psilocybin therapy is legal in Colorado, Oregon, and New Mexico; legislative efforts in New York and California underway.
• Issues with underground (unregulated) products: Adulteration, misinformation, and safety concerns.
  • Alli: “Most of the brands [in bodegas]...are not actually psilocybin. The danger of the underground market is people misreading, thinking this is psilocybin and having a terrible experience because they’re eating too much or there’s no education around it.” (54:50)

Memorable Quotes & Moments with Timestamps

• Alli: “The journey of your life can so often be defined by the substances you ingest. Some substances move you into your heart and some into your head. And psychedelics, when used intentionally, can move you into your heart. The world needs that desperately.” (59:55)
• Alli: “I can’t imagine not having access to these tools. I’m really just grateful I’ve been able to interact with them and learn how to work with them consciously.” (21:40)
• Michael: “I care more about what people are going to categorize me as... Is it an intentional thing for you or are you wrapped up in the identity you’ve created through this sober person thing?” (39:00)
• Alli: “I think SSRIs and pharmaceuticals have a time and place, but they’re way over-prescribed. [Microdosing] can support people without having to create dependency.” (26:14)
• Michael: “When I found out my dad died, the first thought I had was, I’m so glad I was able to introduce mushrooms to my parents.” (05:35)
• Alli: “If I had any idea how difficult it was, I would never have intended to start a nonprofit focused on policy. But it’s been fascinating bridging the gap between government and culture.” (56:26)

Key Segments & Timestamps

• [00:00 - 05:54]: Introduction, ancient use of mushrooms, Alli’s family story of introducing her parents to mushrooms.
• [09:17 - 11:28]: Michael’s sobriety dilemma—considering psilocybin in the context of recovery.
• [12:10 - 17:25]: Functional vs. psychedelic mushrooms; science, neuroplasticity, brain pathways, and emotional healing.
• [19:26 - 22:36]: Are mushrooms a gift from God? Spiritual and historical perspectives.
• [24:12 - 27:59]: Comparison of SSRIs, Adderall, and psychedelics for mental health, especially ADHD and depression.
• [30:38 - 34:38]: The paradox of psychedelics in recovery: legality, harm reduction, and the AA founder’s use of psychedelics.
• [34:38 - 42:26]: Michael’s personal fears and trauma; the potential for psychedelics to help with deep-rooted issues; status of legalization and ongoing destigmatization.
• [43:56 - 47:12]: Alli shares the SuperMush company story; how functional mushrooms shifted her health and business journey.
• [47:25 - 52:10]: Nonprofit advocacy, microdosing collective stories (e.g., life-changing neuro-recovery, headaches).
• [54:00 - 58:05]: Legalization models, consumer protection issues, and policy lessons from cannabis/future of psychedelic policy.
• [58:05 - END]: The importance of intention, education, and set/setting in exploring psychedelics; Michael’s takeaways and closing reflections.

Final Takeaways

• Education & Intentional Use: Both the host and guest repeatedly stress that the benefits of mushrooms—functional or psychedelic—are maximized by informed, intentional use and proper support.
• Sobriety & Stigma: The topic of microdosing for those in recovery is fraught with inner conflict and social stigma, but new science and shared stories suggest a possible new path for healing old wounds.
• Legal Access & Safety: Advocacy is key; safe, well-regulated access is necessary to prevent harm and ensure the therapeutic potential of these ancient substances is realized safely in modern society.

Additional Resource Links

• SuperMush: supermush.com
• Microdosing Collective: microdosingcollective.org
• Brain scan research (Dr. Robin Carhart-Harris): See imaging on effects of psilocybin on neural pathways.
• Recommended Reading: “The Psychedelic Explorer’s Guide” by James Fadiman.

This episode is a must-listen for anyone curious about the intersection of neuroscience, spirituality, recovery, and the evolving landscape of plant medicine.